Friday, May 1, 2026

Korea–U.S. Trade Tensions: Why Seoul Rejects Claims Tying 25% Tariffs to Legislative Delays

Minister Cho Hyun clarifies that Trump's tariff increase is unrelated to Coupang and emphasizes the need for parliamentary consent on trade matters.

South Korea Inc. Defies Tariffs in North America: Sales Jump 14% to $257B, Now 31% of Revenue

South Korean firms saw a 14% rise in North American sales, driven by IT and pharmaceuticals, while construction and batteries declined.

NeMo Microservices: Nvidia’s All-in-One Platform for Smarter AI Teams

Nvidia officially launched 'NeMo microservices' to accelerate the development of enterprise AI agents on the 25th.

Tag: Alzheimer's

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

MSD Korea Announced at Bio Korea 2026 that Korea is a Crucial Hub for Global Innovation

Korea is now a key innovation hub for MSD, focusing on neuroscience and clinical research collaborations, with significant R&D investments.

Significant Weight Loss Substantially Increases Mortality Risk in Dementia Patients

A study finds dementia patients with significant weight loss face higher mortality risks, while stable weight or moderate gain lowers risks.

Unlocking Alzheimer’s: The Surprising Role of Tau Protein in Cell Division Revealed

POSTECH researchers reveal tau protein's new role in DNA interaction, impacting Alzheimer's, infertility, and congenital disorders.

Neurophet AQUA AD Plus: Revolutionizing Alzheimer’s Diagnosis with AI at AD/PD 2026

Neurophet showcased its AI solutions for Alzheimer's at AD/PD 2026, aiming to foster collaborations in treatment development.

Korean Medical AI Lands at the University of Washington: Neurofit Signs U.S. Deal for Brain MRI + PET Analysis Tools

Neurofit signs a contract to supply AI medical solutions to the University of Washington, marking its U.S. market entry and expansion.

How Neurophet AQUA is Transforming Dementia Diagnosis in South Korea: Key MOU Insights

Neurophet partners with Eisai Korea to enhance dementia screening and diagnostics using AI-based software, Neurophet AQUA.

Early-Onset Dementia: The Growing Need for Early Detection and Prevention

Early-onset dementia affects those under 65, with symptoms requiring early recognition and treatment for better outcomes.

Study Reveals: Taking Statins for 3 Years Can Slash Dementia Risk by 63%!

A study reveals statins can reduce dementia risk by 63%, especially in diabetic patients, highlighting their protective benefits.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.